Advanced Biomed (NASDAQ:ADVB) Posts Quarterly Earnings Results

Advanced Biomed (NASDAQ:ADVB) issued its quarterly earnings data on Friday. The company reported $0.32 earnings per share (EPS) for the quarter, Zacks reports.

Advanced Biomed Stock Up 1.1%

Shares of Advanced Biomed stock opened at $0.24 on Friday. Advanced Biomed has a 1-year low of $0.21 and a 1-year high of $4.10.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings started coverage on shares of Advanced Biomed in a report on Monday, January 26th. They set a “sell (e+)” rating on the stock. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has an average rating of “Sell”.

About Advanced Biomed

Our Mission We are committed to the application research of integrating semiconductor technology and biotechnology. Through the enrichment, capture, and identification of circulating tumor cells and related tumor marker cells in the field of liquid biopsy, we aim to provide cancer patients with rapid and affordable assay products and services. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. We are a holding company incorporated in the State of Nevada.